为解决风湿性多肌痛 (PMR)长期死亡率数据缺乏的问题，挪威学者开展了一项历时38年、纳入337例患者的前瞻性队列研究。通过标准死亡率比 (SMR)和Kaplan-Meier生存分析证实，单纯性PMR患者全因死亡率与普通人群无差异 (SMR 0.97, 95%CI 0.85-1.09)，男性患者甚至呈现更低死亡率 (SMR 0.77)。该研究为PMR预后评估提供了最高等级循证证据。

风湿性多肌痛 (PMR)作为老年群体第二常见的炎症性风湿病 (仅次于类风湿关节炎RA)，与巨细胞动脉炎同属疾病谱系。2024版S2e指南基于2016-2024年系统性文献分析，由跨国专家团队制定7项创新建议： 治疗方面，确诊后应立即启动糖皮质激素 (15-25mg/天泼尼松当量)并逐步减量，同时监测治疗反应与副作用 ...

In a long-term follow-up study, patients with isolated polymyalgia rheumatica (PMR) and biopsy-confirmed giant cell arteritis (GCA) had no increased all-cause mortality compared with matched ...

PMR provides a framework for achieving this state of relaxation. It requires you to work on one muscle group at a time, allowing you to notice the tension in that specific area.

If you have polymyalgia rheumatic (PMR), changes in your diet may help you manage symptoms. Learn more about the do’s and don’ts for eating with PMR.

The U.S. Food and Drug Administration (FDA) has approved a new biologic treatment option for patients with a common inflammatory disorder known as polymyalgia rheumatica (PMR) who don’t do well ...

TOPLINE: ABBV-154, an antibody-drug conjugate comprising adalimumab conjugated to a proprietary glucocorticoid receptor modulator, shows potential for extending flare-free periods in patients with ...